4 Einträge gefunden

1. Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C

   1. Larrey, Dominique
   2. Lohse, Ansgar W
   3. Trepo, Christian
   4. Bronowicki, Jean-Pierre
   5. Arastéh, Keikawus
   6. Bourlière, Marc
   7. Calleja, Jose Luis

   2013 - Forschungsinformationssystem des UKE
2. Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results

   1. Zeuzem, Stefan
   2. Asselah, Tarik
   3. Angus, Peter
   4. Zarski, Jean-Pierre
   5. Larrey, Dominique
   6. Müllhaupt, Beat
   7. Gane, Ed

   2013 - Forschungsinformationssystem des UKE
3. Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin.

   1. Larrey, Dominique
   2. Lohse, Ansgar W.
   3. de Ledinghen, Victor
   4. Trepo, Christian
   5. Gerlach, Tilman
   6. Zarski, Jean-Pierre
   7. Tran, Albert

   2012 - Forschungsinformationssystem des UKE
4. Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.

   1. Zeuzem, Stefan
   2. Asselah, Tarik
   3. Angus, Peter
   4. Zarski, Jean-Pierre
   5. Larrey, Dominique
   6. Müllhaupt, Beat
   7. Gane, Ed

   2011 - Forschungsinformationssystem des UKE